Gaston-Dreyfus Remi 4
4 · Bionik Laboratories Corp. · Filed Jun 21, 2022
Insider Transaction Report
Form 4
Gaston-Dreyfus Remi
Director
Transactions
- Conversion
Common Stock, par value $0.001 per share
2022-03-31$9.50/sh+77,887$739,927→ 1,616,840 total(indirect: Shares held through GD Holdings and Lombard International Assurance SA)
Holdings
- 61,256
Common Stock, par value $0.001 per share
Footnotes (1)
- [F1]Effective as of March 31, 2022, an aggregate amount of $739,926 of principal and accrued interest in a convertible promissory note issued to GD Holdings converted in accordance with its terms into 77,887 shares of the Issuer's common stock.